Suppr超能文献

比较穿透性角膜移植术和深板层角膜移植术治疗圆锥角膜的系统评价。

Systematic review comparing penetrating keratoplasty and deep anterior lamellar keratoplasty for management of keratoconus.

作者信息

Henein Christin, Nanavaty Mayank A

机构信息

Sussex Eye Hospital, Brighton & Sussex University H ospitals NHS Trust, Eastern Road, Brighton, BN6 5BF, United Kingdom.

Sussex Eye Hospital, Brighton & Sussex University H ospitals NHS Trust, Eastern Road, Brighton, BN6 5BF, United Kingdom.

出版信息

Cont Lens Anterior Eye. 2017 Feb;40(1):3-14. doi: 10.1016/j.clae.2016.10.001. Epub 2016 Oct 29.

Abstract

AIM

Perception of reduced incidence of graft rejection after deep anterior lamellar keratoplasty (DALK) has attracted many surgeons towards this technique in keratoconus. This review aims to compare the visual, refractive and graft outcomes after penetrating keratoplasty (PK) and DALK for keratoconus.

METHODS

Electronic searches of PubMed, MEDLINE, EMBASE, Latin American and Caribbean Health Sciences Literature database (LILACS), metaRegister of Controlled Trials (mRCT), ClinicalTrial.gov and the WHO International Clinical Trials Registry Platform (ICTRP) were performed. We included randomized control trials (RCTs) and comparative studies to assess primary and secondary outcomes after PK and DALK in eyes with keratoconus. Primary outcome was best-corrected visual acuity (BCVA) LogMAR at ≥6 months. Secondary outcomes included number of patients with BCVA≥0 LogMAR, uncorrected visual acuity (UCVA) LogMAR, spherical equivalent (SE), refractive and keratometric astigmatism, endothelial cell density (ECD) cell/mm, graft rejection and graft survival.

RESULTS

Eighteen studies (including 2 RCTs) compared DALK (965 eyes) and PK (2402 eyes) for keratoconus. There was strong evidence through RCTs suggesting better LogMAR BCVA at ≥6 months and better LogMAR UCVA with PK; reduced refractive astigmatism and rejection with DALK and no difference in SE and keratometric astigmatism. Moreover, there was weak evidence to suggest better BCVA≥0 LogMAR after PK and no difference in ECD between the two techniques.

CONCLUSIONS

Despite the popularity of DALK amongst corneal surgeons for keratoconus, there is a paucity of high quality RCTs. The existing limited evidence confirms reduced rejection and refractive astigmatism with DALK but better visual outcomes with PK. Internationally agreed data sets and follow-up protocol are warranted.

摘要

目的

深前板层角膜移植术(DALK)后移植物排斥反应发生率降低的观念吸引了许多外科医生在圆锥角膜治疗中采用该技术。本综述旨在比较穿透性角膜移植术(PK)和DALK治疗圆锥角膜后的视力、屈光和移植物结局。

方法

对PubMed、MEDLINE、EMBASE、拉丁美洲和加勒比健康科学文献数据库(LILACS)、对照试验元注册库(mRCT)、ClinicalTrial.gov和世界卫生组织国际临床试验注册平台(ICTRP)进行电子检索。我们纳入了随机对照试验(RCT)和比较研究,以评估PK和DALK治疗圆锥角膜眼后的主要和次要结局。主要结局是≥6个月时的最佳矫正视力(BCVA)LogMAR。次要结局包括BCVA≥0 LogMAR的患者数量、未矫正视力(UCVA)LogMAR、等效球镜度(SE)、屈光性和角膜散光、内皮细胞密度(ECD,细胞/mm²)、移植物排斥反应和移植物存活情况。

结果

18项研究(包括2项RCT)比较了DALK(965只眼)和PK(2402只眼)治疗圆锥角膜的效果。RCT有力证据表明,PK在≥6个月时的LogMAR BCVA更好,LogMAR UCVA也更好;DALK的屈光性散光和排斥反应减少,SE和角膜散光无差异。此外,有微弱证据表明PK后BCVA≥0 LogMAR更好,两种技术的ECD无差异。

结论

尽管DALK在角膜外科医生中治疗圆锥角膜很受欢迎,但高质量的RCT较少。现有有限证据证实DALK的排斥反应和屈光性散光减少,但PK的视力结局更好。需要国际认可的数据集和随访方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验